Azitra, Inc. (AZTR) vs Lunai Bioworks Inc. (LNAI)

Azitra, Inc. and Lunai Bioworks Inc. are both Biotechnology companies. Azitra, Inc. and Lunai Bioworks Inc. are of similar size ($4.3M and $4.2M). Lunai Bioworks Inc. has negative trailing earnings, so its P/E is not meaningful; Azitra, Inc. trades at 1.0×. Azitra, Inc. has the higher net margin (0.00% vs −3,761.9%) and the lower return on invested capital (−1,272.5% vs 0.00%). Across the 14 metrics below, Azitra, Inc. leads on 9 and Lunai Bioworks Inc. on 5.

Valuation

Metric AZTR LNAI Biotechnology median
P/E 1.05 n/m 8.50
P/S 2.33 24.13 9.71
P/B 0.18 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.48 n/m 0.64
EV/Sales (9.26) 18.71 9.21
Earnings yield 95.57% (150.78%) (33.15%)
Free cash flow yield (842.70%) (232.47%) (25.50%)

Profitability

Metric AZTR LNAI Biotechnology median
Gross margin 100.00% (3.48%) 65.16%
Operating margin 0.00% (9,184.79%) 0.00%
Net margin 0.00% (3,761.88%) 0.00%
Free cash flow margin 0.00% (5,610.24%) 0.00%
Return on equity (256.67%) 23.46% (56.36%)
Return on assets (190.69%) (39.21%) (48.04%)
Return on invested capital (1,272.49%) 0.00% 0.00%

Growth

Metric AZTR LNAI Biotechnology median
Revenue growth (TTM) 58.18% — 6.02%
EPS growth (last fiscal year) 85.67% 98.77% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AZTR LNAI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.86 0.11 4.72
Net debt to EBITDA 0.20 0.20 0.96

Dividend

Metric AZTR LNAI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AZTR LNAI Biotechnology median
Market cap 4.33m 4.15m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack